Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3503495 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3288792 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1265010 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3501621 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1896403 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3503524 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3503187 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL2559740 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1060504 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1065093 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1022 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325970-A1 | CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF | UNIV SICHUAN (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4527872-A1 | CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF | Sichuan University (CN) | 2025-03-26 | — | — | EP | claimed |
| CN-118255666-A | Preparation method and application of vegetable oil polyol | 广东腐蚀科学与技术创新研究院 | 2024-06-28 | — | — | CN | claimed |
| WO-2023231524-A1 | CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF | 四川大学 | 2023-12-07 | — | — | WO | claimed |
| CN-115137092-B | Method for preparing tobacco extract by using low-temperature plasma-assisted ionic liquid | 江西中烟工业有限责任公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116769087-A | Preparation method of catalyst for preparing ultra-high molecular weight polyethylene | 湖北昱泓高新材料科技有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-114044886-B | Production method of polycaprolactone | 青岛科技大学 | 2023-08-29 | — | — | CN | claimed |
| CN-116514906-A | Preparation method of Cyclo (Pro-Glu-Phe) | 宜宾五粮液股份有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-112946129-B | Quality detection method of antidiarrheal syrup | 桂林三金药业股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-116253640-A | Vegetable oil polyol and preparation method and application thereof | 南京工业大学 | 2023-06-13 | — | — | CN | claimed |
| WO-2001040320-A1 | CATALYST FOR POLYMERIZATION AND CO-POLYMERIZATION OF ETHYLENE | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2001-06-07 | — | — | WO | claimed |
| EP-0879058-B1 | MIXTURES DERIVED FROM GRAINS OF EUGENIA JAMBOLANA LAMARCK, PREPARATION AND USE OF SAID MIXTURES AND SOME OF THEIR CONSTITUENTS AS MEDICAMENTS | INST MALGACHE DE RECH S APPLIQ (MG) | 2001-06-06 | — | — | EP | claimed |
| EP-1063235-A1 | BENZOFURYLPYRONE DERIVATIVES | TEIJIN LIMITED (JP) | 2000-12-27 | — | — | EP | claimed |
| WO-2000073356-A1 | A CATALYST FOR ETHYLENE HOMO- AND CO-POLYMERIZATION | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2000-12-07 | — | — | WO | claimed |
| WO-2000073355-A1 | A CATALYST FOR ETHYLENE HOMO- AND CO-POLYMERIZATION | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2000-12-07 | — | — | WO | claimed |
| US-5972342-A | ANTIDIABETIC AGENTS | RHONE-POULENC RORER S.A. (FR) | 1999-10-26 | — | — | US | claimed |
| US-5380936-A | Thermal rearrangements | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-01-10 | — | — | US | claimed |
| EP-0453515-A4 | COMPOSITION AND METHOD FOR TREATMENT OF SENILE DEMENTIA | — | 1992-05-06 | — | — | EP | claimed |
| EP-0453515-A1 | COMPOSITION FOR TREATMENT OF SENILE DEMENTIA | PANG, Peter K. T. (CA) | 1991-10-30 | — | — | EP | claimed |
| WO-1990008315-A1 | COMPOSITION AND METHOD FOR TREATMENT OF SENILE DEMENTIA | PANG PETER K T (CA) | 1990-07-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325970-A1 | CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF | NOTUM, WEE1, FAR1 | CYP1A2 1249/4885DGKA 1227/4885ALDH1A1 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.